SARS-CoV-2 Nucleocapsid S-RBD Fusion (His Tag)
Immobilized ACE-2 Fc Chimera, Human (Cat. No. Z03484) at 2 μg/mL can bind SARS-CoV-2 Nucleocapsid S-RBD Fusion (His Tag) (Cat. No. Z03505) with a serial dilution.
THETM His Tag Antibody [HRP], mAb, Mouse(Cat.No.A00612) is used as a secondary antibody (0.1 μg/mL).
Lane 1: 1μg of SARS-CoV-2 Nucleocapsid S-RBD Fusion (His Tag), reducing(R)
> 95% as analyzed by SDS-PAGE
| Species | SARS-CoV-2 | ||||
| Protein Construction |
Full length of nucleocapsid protein and spike protein RBD region.
|
||||
| Purity | > 75% as analyzed by SDS-PAGE | ||||
| Endotoxin Level | < 0.2 EU/μg of protein by gel clotting method | ||||
| Biological Activity | SARS-CoV-2 Nucleocapsid S-RBD Fusion (His tag) can bind to both human ACE2 (Cat. No.: Z03484) and nucleocapsid antibody (Cat. No.: A02039) in functional ELISA assay. | ||||
| Expression System | 293 Cells | ||||
| Theoretical Molecular Weight | 74.9 kDa | ||||
| Formulation | Supplied as a solution in PBS pH 7.4 containing 10% glycerol. | ||||
| Concentration | Please refer to the COA for the specific lot. | ||||
| Storage & Stability | Upon receiving, this product remains stable for up to 6 months at -20°C or below. Avoid repeated freeze-thaw cycles. |
Immobilized ACE-2 Fc Chimera, Human (Cat. No. Z03484) at 2 μg/mL can bind SARS-CoV-2 Nucleocapsid S-RBD Fusion (His Tag) (Cat. No. Z03505) with a serial dilution.
THETM His Tag Antibody [HRP], mAb, Mouse(Cat.No.A00612) is used as a secondary antibody (0.1 μg/mL).
Lane 1: 1μg of SARS-CoV-2 Nucleocapsid S-RBD Fusion (His Tag), reducing(R)
> 95% as analyzed by SDS-PAGE
| Target Background | SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus. SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. SARS-CoV-2 Spike Protein (RBD) also has the potential value for the diagnosis of the virus. |
| Synonyms | N+RBD; SARS-CoV-2 S-RBD+N protein; 2019-nCoV S-RBD+N protein; SARS-CoV-2 NP S-RBD fusion |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
For more documents, please visit "Technical Support".
| Cat. No. Z03505 | ||
|---|---|---|
| Size | Price | |
| 100 μg | $380.00 | |
| 1 mg | $2100.00 | |
